Susumu Kitamura
4PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Oct 08, 2020
Long-term analysis of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa: Open-label phase 3 results.Akimichi Morita, Hidetoshi Takahashi, Kentaro Ozawa
|Jul 09, 2019
Twenty-four-week interim analysis from a phase 3 open-label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa.Akimichi Morita, Hidetoshi Takahashi, Kentaro Ozawa
|Jun 26, 2019
Efficacy and safety of risankizumab in Japanese patients with moderate to severe plaque psoriasis: Results from the SustaIMM phase 2/3 trial.Mamitaro Ohtsuki, Hideki Fujita, Mitsunori Watanabe
|Oct 11, 2018
Adalimumab treatment in Japanese patients with generalized pustular psoriasis: Results of an open-label phase 3 study.Akimichi Morita, Fumikazu Yamazaki, Takashi Matsuyama
Pageof 1
